Alison Lawton

Alison Lawton

Patrimonio netto: - $ in data 31/05/2026

63 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Alison Francis Lawton is currently Director at AgBiome INC since 2021, Director at SwanBio Therapeutics, Inc. since 2021, Independent Director at Dianthus Therapeutics, Inc. since 2023, Director at Bluerock Therapeutics, Inc., and President at Cadena Bio, Inc. Former roles include Chairman & President at Regulatory Affairs Professionals Society, Independent Director at Cubist Pharmaceuticals LLC from 2012 to 2014, Director at CoLucid Pharmaceuticals, Inc. from 2016 to 2017, Independent Director at Spyre Therapeutics, Inc. from 2020 to 2024, Director at Follica, Inc., Director at Massachusetts Medical Device Industry Council, Independent Director at Verastem, Inc. from 2012 to 2020, Director at Kaleido Biosciences, Inc. in 2020, Director at Magenta Therapeutics, Inc. from 2017 to 2018, Independent Director at Magenta Therapeutics, Inc. from 2020 to 2021, Independent Director at X4 Pharmaceuticals, Inc. from 2020 to 2025, Senior Vice President at Genzyme Corp.
from 2011 to 2012, Chief Operating Officer at Aura Biosciences, Inc. from 2015 to 2017, Principal at Parke-Davis & Co. Ltd., General Manager at Genzyme Biosurgery Corp.
from 2012 to 2013, General Manager-Biosurgery at Sanofi, Inc., Chief Operating Officer at OvaScience, Inc. from 2013 to 2014, Head-Genzyme Biosurgery at Sanofi-Aventis, Inc., Chief Operating Officer at X4 Pharmaceuticals, Inc. from 2014 to 2017, Senior Vice President & General Manager at BIOSURGERY S.R.L., and Independent Member-Supervisory Board at ProQR Therapeutics NV from 2014 to 2026.
Education includes undergraduate studies at King's College London.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
18/03/2026 0 ( -.--% ) - $ 31/05/2026
21/05/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Alison Lawton

SocietàPosizioneInizio
DIANTHUS THERAPEUTICS, INC. Presidente 11/09/2023
Presidente -
Direttore/Membro del Consiglio 04/05/2021
Direttore/Membro del Consiglio 19/01/2021
Direttore/Membro del Consiglio -

Precedenti posizioni note di Alison Lawton

SocietàPosizioneFine
PROQR THERAPEUTICS N.V. Direttore/Membro del Consiglio 02/06/2026
X4 PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 09/06/2025
SPYRE THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/02/2024
KALEIDO BIOSCIENCES, INC. Amministratore Delegato 16/06/2020
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Alison Lawton

Formazione di Alison Lawton

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

90

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private25

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

  1. Mercati
  2. Insiders
  3. Alison Lawton
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA